Home
>
National Drug Code (NDC)
>
Fenofibrate
Fenofibrate - 0378-3066-93 - (fenofibrate)
Drug Information of Fenofibrate
| Product NDC: | 0378-3066 |
| Proprietary Name: | Fenofibrate |
| Non Proprietary Name: | fenofibrate |
| Active Ingredient(s): | 145 mg/1 & nbsp; fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fenofibrate
| Product NDC: | 0378-3066 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202856 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130521 |
Package Information of Fenofibrate
| Package NDC: | 0378-3066-93 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3066-93) |
NDC Information of Fenofibrate
| NDC Code | 0378-3066-93 |
| Proprietary Name | Fenofibrate |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3066-93) |
| Product NDC | 0378-3066 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fenofibrate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130521 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | FENOFIBRATE |
| Strength Number | 145 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
